Arq (ARQ) Q2 2026 Earnings Call Transcript
Arq (ARQ) held its Q2 2026 earnings call, citing revenue of about $30 million, gross margin around 38.5% (up ~520 bps), and adjusted EBITDA of about $5.8 million. The company discussed PAC for PFAS for near-term compliance ahead of EPA PFAS rules, and reiterated full-year CapEx of $8 million to $10 million.
How this was made
The 30-second read
Why it matters
Traders can update expectations for 2026 profitability and 2027-2028 growth drivers based on reiterated CapEx, margin expansion from reduced GAC start-up drag, and the timing of PFAS compliance milestones (monitoring/reporting beginning Q2 2027, tighter thresholds 2029-2031).
Market read
Q2 metrics and reiterated CapEx provide near-term financial anchors, while PAC for PFAS and the GAC optimization review provide a longer-dated catalyst tied to PFAS compliance timelines.
What to watch
The call notes the strategic optimization review is ongoing and that PAC for PFAS trials are ongoing with no material 2026 contribution, so near-term fundamentals may depend more on execution of cost/capacity initiatives than on the new product.
Background
ARQ’s call centers on powdered activated carbon (PAC) as the core business, progress on granular activated carbon (GAC) optimization, and a new PAC for PFAS product aimed at upcoming U.S. PFAS monitoring and compliance thresholds.
Ticker impact
ARQ reported Q2 2026 revenue of about $30M, gross margin about 38.5%, and reiterated full-year CapEx of $8M to $10M.
Moderately positive bias for near-term trading, with upside tied to any follow-through on PAC for PFAS trials and the ongoing GAC optimization review.
The article contains concrete quarterly financial metrics and guidance, plus a specific product/compliance catalyst for 2027-2031. However, it explicitly says no material contribution is expected for the remainder of 2026, limiting immediate upside.
Market effects
Reinforces demand strength for PFAS treatment solutions and suggests a potential shift from higher-capex GAC toward powdered activated carbon for certain utilities.
No specific regional demand or regulatory change is disclosed beyond U.S. water-company compliance timelines.
Primarily U.S.-regulatory driven (EPA PFAS standards and monitoring/reporting), with limited direct global implications stated.
Counterpoint
PAC for PFAS may not scale if the contamination upper limit is not confirmed or if customers ultimately still require GAC for compliance.
Key entities
- public_companyARQ
Powdered activated carbon and PFAS treatment solutions provider; reported Q2 2026 results and discussed PAC for PFAS and GAC optimization.
- executiveShimon Steinmetz
Appointed Chief Financial Officer, described as bringing efficiency and financial productivity ideas.
